---
title: GNS Healthcare Blog | R&D
description: R&D |
---
- [Blog](https://blog.gnshealthcare.com/)
- [Careers](https://www.gnshealthcare.com/careers/)
- [Twitter](https://twitter.com/gnshealthcare)
- [LinkedIn](https://www.linkedin.com/company/gns-healthcare/)
- [YouTube](https://www.youtube.com/channel/UC8RbKPCoi9Y-8BG_rEZEOXg)
[](https://www.gnshealthcare.com/)
- Solutions
- [REFS Platform](https://www.gnshealthcare.com/refs-platform/)
- [Subpopulations](https://www.gnshealthcare.com/subpopulations/)
- [Value-based Drug Models](https://www.gnshealthcare.com/value-based-drug-models/)
- [Intervention Optimization](https://www.gnshealthcare.com/intervention-optimization/)
- [Customized Modeling](https://www.gnshealthcare.com/customized-modeling/)
- Who We Serve
- [Biopharma](https://www.gnshealthcare.com/biopharma/)
- [Health Plans](https://www.gnshealthcare.com/health-plans/)
- [Foundations](https://www.gnshealthcare.com/foundations/)
- Results
- [The Power of Causal Machine Learning](https://www.gnshealthcare.com/the-power-of-causal-machine-learning/)
- [Journal Articles](https://www.gnshealthcare.com/journal-articles/)
- [Posters](https://www.gnshealthcare.com/posters/)
- [News & Events](https://www.gnshealthcare.com/news/)
- [Blog](https://blog.gnshealthcare.com/)
- [In the News](https://www.gnshealthcare.com/news/#news)
- [Events](https://www.gnshealthcare.com/news/#events)
- [Press Releases](https://www.gnshealthcare.com/news/#press-releases)
- [GNS Precision Medicine Forum](https://www.gnshealthcare.com/gns-precision-medicine-forum/)
- About Us
- [Leadership](https://www.gnshealthcare.com/leadership/)
- [Board of Directors](https://www.gnshealthcare.com/board-of-directors/)
- [Strategic Advisory Board](https://www.gnshealthcare.com/strategic-advisory-board/)
- [Our Culture](https://www.gnshealthcare.com/culture/)
- [Careers](https://www.gnshealthcare.com/careers/)
- [Contact](https://www.gnshealthcare.com/contact/)
- [Request Info](https://info.gnshealthcare.com/request-info-website)
- [Blog](https://blog.gnshealthcare.com/)
- [Careers](https://www.gnshealthcare.com/careers/)
## GNS Healthcare Blog
# GNS Healthcare Blog
## GNS Healthcare Primary Blog
By December 31, 1969
Feb 21
[](https://info.aitiabio.com/new-world-drug-development)
## [The New World of Drug Development: Transforming Clinical Trials with AI](https://info.aitiabio.com/new-world-drug-development)
By [GNS Healthcare](https://info.aitiabio.com/author/gns-healthcare) | [Clinical Trials](https://info.aitiabio.com/topic/clinical-trials), [Drug Development](https://info.aitiabio.com/topic/drug-development), [AI](https://info.aitiabio.com/topic/ai), [R&D](https://info.aitiabio.com/topic/rd)
*The following is the second in a three-part series on the impact of AI on the product development life cycle of drugs from discovery, to clinical trials and market access.*
The success of clinical trials relies heavily on having enough of the right patients willing and able to participate. Unfortunately, achieving the levels of recruitment necessary to conduct successful trials is difficult – particularly in cancer and rare diseases trials.
One recent survey revealed that only one in three cancer patients were likely to enroll in a clinical trial. Less than half of those surveyed viewed...
[Read More](https://info.aitiabio.com/new-world-drug-development)
Feb 14
[](https://info.aitiabio.com/ai-drug-development-perfect-partners)
## [Drug Discovery and AI: An Unlikely Marriage or Perfect Partners?](https://info.aitiabio.com/ai-drug-development-perfect-partners)
By [GNS Healthcare](https://info.aitiabio.com/author/gns-healthcare) | [Drug Development](https://info.aitiabio.com/topic/drug-development), [AI](https://info.aitiabio.com/topic/ai), [R&D](https://info.aitiabio.com/topic/rd)
*The following is the first in a three-part series on the impact of AI on the product development life cycle of drugs from discovery, to clinical trials and market access.*
Biopharma companies and government funded research projects have produced stellar results over the years: from lifesaving drugs and to life improving therapies that benefit millions of patients. But these discoveries often come at a substantial financial cost and take many years to bring to market. In fact, the cost of bringing one drug from discovery to approval is currently estimated at between $1.8 and $3.0 billion.[\[1\]](https://info.aitiabio.com/topic/rd#_ftn1)
[Read More](https://info.aitiabio.com/ai-drug-development-perfect-partners)
Feb 07
[](https://info.aitiabio.com/oncology-research-leading-the-charge)
## [Follow the Tumor: How Oncology R&D is Leading the Charge in AI Implementation](https://info.aitiabio.com/oncology-research-leading-the-charge)
By [GNS Healthcare](https://info.aitiabio.com/author/gns-healthcare) | [Cancer Treatment](https://info.aitiabio.com/topic/cancer-treatment), [oncology](https://info.aitiabio.com/topic/oncology), [AI](https://info.aitiabio.com/topic/ai), [R&D](https://info.aitiabio.com/topic/rd)
In 2017, the American Cancer Society awarded $112 million for cancer research.[\[1\]](https://info.aitiabio.com/topic/rd#_ftn1) The National Institute of Health FY17 budget for cancer research was nearly $6 billion.[\[2\]](https://info.aitiabio.com/topic/rd#_ftn2)
Pharma companies are pouring billions of R&D dollars into developing new treatments for cancer and are looking for the best ways to maximize those investments. One of the, most effective research tools available and one increasingly leveraged by biopharma is artificial intelligence (AI), used to help unlock the complex mechanisms of cancer.
Oncology is an enormously complicated field, so it’s no surprise that...
[Read More](https://info.aitiabio.com/oncology-research-leading-the-charge)
### Subscribe to the GNS Newsletter
Search:
Search
### Follow Us:
### Recent Posts:
### Categories:
- [AI (29)](https://info.aitiabio.com/topic/ai)
- [Precision Medicine (21)](https://info.aitiabio.com/topic/precision-medicine)
- [Artificial Intelligence (20)](https://info.aitiabio.com/topic/artificial-intelligence)
- [Machine Learning (20)](https://info.aitiabio.com/topic/machine-learning)
- [Future (13)](https://info.aitiabio.com/topic/future)
- [Big Data (12)](https://info.aitiabio.com/topic/big-data)
- [Healthcare (11)](https://info.aitiabio.com/topic/healthcare)
### Twitter
[Tweets by @gnshealthcare](https://twitter.com/gnshealthcare)
**About GNS Healthcare**
By leveraging the most powerful form of AI, called causal machine learning, we transform massive and diverse data streams to precisely match therapeutics, procedures, and care management interventions to individuals. We understand that in order to make precision medicine a reality, we need to discover and deliver insights that will cure disease and heal the healthcare system.
[Privacy Policy](https://www.gnshealthcare.com/privacy-policy)
**Contact Us**
196 Broadway
Cambridge, MA 02139
Email: [info@gnshealthcare.com](mailto:info@gnshealthcare.com)
Phone: 617.374.2300
- [Twitter](https://twitter.com/gnshealthcare)
- [LinkedIn](https://www.linkedin.com/company/gns-healthcare/)
- [YouTube](https://www.youtube.com/channel/UC8RbKPCoi9Y-8BG_rEZEOXg)
© GNS Healthcare 561 Windsor St. A200, Somerville, MA 02143 | 617-374-2300